{"_meta":{"attribution":"Data aggregated by pdata.world (https://pdata.world) from Polymarket, Kalshi, Manifold, Myriad, Limitless, Predict, Opinion and Gemini; CC BY 4.0; source data © each venue.","canonical_url":"https://pdata.world/events/kalshi/KXEARNINGSMENTIONABBV-27FEB03","as_of":"2026-11-22T00:15:47.426674Z","docs":"https://api.pdata.world/docs","cite_as":"According to pdata.world (tracking Kalshi): \"What will AbbVie say during their next earnings call?\" — 14 markets; highest \"Vyalev (3+ times)\" at 42% as of 2026-11-21 UTC. https://pdata.world/events/kalshi/KXEARNINGSMENTIONABBV-27FEB03","source_url":"https://kalshi.com/markets/kxearningsmentionabbv/what-will-abbvie-say-during-their-next-earnings-call/kxearningsmentionabbv-27feb03","data_as_of":"2026-11-21T23:52:25.242022Z","full_record":"https://api.pdata.world/api/v1/events/kalshi/KXEARNINGSMENTIONABBV-27FEB03","price_history":"https://api.pdata.world/api/v1/events/kalshi/KXEARNINGSMENTIONABBV-27FEB03/history?range=7d&limit=20"},"kind":"live","venue":"Kalshi","source":"kalshi","id":"KXEARNINGSMENTIONABBV-27FEB03","title":"What will AbbVie say during their next earnings call?","status":"open","categories":["Mentions"],"closes_at":"2027-02-17T15:00:00Z","outcomes_are":"independent markets, each resolving on its own","volume_24h":0.0,"volume_total":150.0,"volume_unit":"contracts, as Kalshi reports them","outcomes_total":14,"outcomes":[{"name":"Vyalev (3+ times)","probability":0.42,"change_24h":0.42,"volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-VYAL"},{"name":"Elahere (2+ times)","probability":0.37,"change_24h":0.37,"volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-ELAH"},{"name":"Apogee","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-APOG"},{"name":"Botox (3+ times)","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-BOTO"},{"name":"China","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-CHIN"},{"name":"Dividend","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-DIVI"},{"name":"GLP-1 / GLP","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-GLP1"},{"name":"Humira (2+ times)","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-HUMI"},{"name":"Medicare","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-MEDI"},{"name":"Patent / Patented","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-PATE"},{"name":"Tariff","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-TARI"},{"name":"TSLP","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-TSLP"},{"name":"Venclexta (3+ times)","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-VENC"},{"name":"Zumilokibart","volume_24h":0.0,"market_id":"KXEARNINGSMENTIONABBV-27FEB03-ZUMI"}],"rules":"If Vyalev (3+ times) is said by any AbbVie representative (including the operator of the call) during the next AbbVie live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.\n\n---\n\nHow this is resolved\nVideo of AbbVie earnings call.\nIf a consensus by Kalshi employees cannot be reached using video, transcripts of AbbVie earnings call will be used according to the news publications listed in the contract. \n\nPayout criteria\nThe exact phrase/word, or a plural or possessive form of the phrase/word.\n\nDoesn't count for payout\nGrammatical/tense inflections.\n\nKalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners.","rules_apply_to":"the first outcome listed; each other outcome has its own text, in the full record"}